Metabolic Dysfunction-Related Fatty Liver Disease Increases Risk for Colon Cancer
Researchers analyzed the relationship between metabolic dysfunction-associated fatty liver disease and the risk for colon cancer.
Liver
Increased Physical Activity May Reduce Risk for NAFLD
Investigators assessed the effects of different levels of physical activity on the prevalence of nonalcoholic fatty liver disease and its association with metabolic health.
Statin Use May Decrease Cancer-Related Mortality in Nonalcoholic Fatty Liver Disease
Researchers evaluated the effects of statin use on cancer mortality in patients with nonalcoholic fatty liver disease.
Efficacy of Antihyperglycemic Drugs for the Treatment of NAFLD and NASH
Investigators examined the effects of certain antihyperglycemic drugs as treatment for NAFLD or NASH in patients with or without type 2 diabetes.
Lean Patients at Similar Risk for Poor Outcomes, Mortality as Patients Classified As Non-Lean With NAFLD
Investigators assessed baseline characteristics and long-term outcomes of White patients classified as lean with nonalcoholic fatty liver disease.
Early Drop in Systolic BP Linked to Worse CV, Renal Function in Acute Heart Failure
Researchers examined the relationship between a drop in systolic BP, worsening renal function, and prognosis in people with acute heart failure.
Exploring the Relationship Between Muscle Mass and NAFLD
The understudied relationship between muscle mass and nonalcoholic fatty liver disease is assessed, including expert opinions the topic.
Maternal Obesity May Up Risk for Future Liver Disease in Offspring
There is a strong association between maternal weight and future nonalcoholic fatty liver disease in offspring.
SGLT2i and GLP-1RA May Improve Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus
Investigators examined the safety and efficacy of SGLT2i and GLP-1RA on treatment of nonalcoholic fatty liver disease in type 2 diabetes mellitus.
- Loading...
Loading...
Next post in Type 2 Diabetes
Loading... 
Loading...